ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis - Nature - Alert Breaking News - United States Alert Breaking News - US, 28 May 2022 Liu, H. et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss.